These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30703500)

  • 21. Topical and cutaneous delivery using nanosystems.
    Roberts MS; Mohammed Y; Pastore MN; Namjoshi S; Yousef S; Alinaghi A; Haridass IN; Abd E; Leite-Silva VR; Benson H; Grice JE
    J Control Release; 2017 Feb; 247():86-105. PubMed ID: 28024914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsulation of Flavours and Fragrances into Polymeric Capsules and Cyclodextrins Inclusion Complexes: An Update.
    Perinelli DR; Palmieri GF; Cespi M; Bonacucina G
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chapter 10 - Solid lipid nanoparticles and microemulsions for drug delivery The CNS.
    Gasco MR; Priano L; Zara GP
    Prog Brain Res; 2009; 180():181-92. PubMed ID: 20302835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of cyclodextrins and associated toxicities: A roadmap for high quality biomedical applications.
    Trotta F; Loftsson T; Gaud RS; Trivedi R; Shende P
    Carbohydr Polym; 2022 Nov; 295():119880. PubMed ID: 35988985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications.
    Moya-Ortega MD; Alvarez-Lorenzo C; Concheiro A; Loftsson T
    Int J Pharm; 2012 May; 428(1-2):152-63. PubMed ID: 22388054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of cyclodextrins nanoparticles for oral delivery.
    Kanwar JR; Long BM; Kanwar RK
    Curr Med Chem; 2011; 18(14):2079-85. PubMed ID: 21517768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silica-based nanosystems for therapeutic applications in the skin.
    Arriagada F; Nonell S; Morales J
    Nanomedicine (Lond); 2019 Aug; 14(16):2243-2267. PubMed ID: 31411537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interactions between cyclodextrins and triglycerides: from emulsion stabilisation to the emergence of a new drug delivery system called "beads"].
    Hamoudi M; Trichard L; Grossiord JL; Chaminade P; Duchêne D; Le Bas G; Fattal E; Bochot A
    Ann Pharm Fr; 2009 Nov; 67(6):391-8. PubMed ID: 19900602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
    Parrot-Lopez H; Perret F; Bertino-Ghera B
    Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.
    Dos Santos Ramos MA; Da Silva PB; Spósito L; De Toledo LG; Bonifácio BV; Rodero CF; Dos Santos KC; Chorilli M; Bauab TM
    Int J Nanomedicine; 2018; 13():1179-1213. PubMed ID: 29520143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery.
    Iqbal HMN; Rodriguez AMV; Khandia R; Munjal A; Dhama K
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):86-93. PubMed ID: 27978790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced analgesic activity by cyclodextrins - a systematic review and meta-analysis.
    Brito RG; Araújo AA; Quintans JS; Sluka KA; Quintans-Júnior LJ
    Expert Opin Drug Deliv; 2015; 12(10):1677-88. PubMed ID: 26159048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
    Jansook P; Pichayakorn W; Muankaew C; Loftsson T
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy.
    Raminelli ACP; Romero V; Semreen MH; Leonardi GR
    Curr Med Chem; 2018; 25(31):3703-3718. PubMed ID: 29532749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex.
    Jambhekar SS; Breen P
    Drug Discov Today; 2016 Feb; 21(2):356-62. PubMed ID: 26686054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research.
    Al-Lawati H; Binkhathlan Z; Lavasanifar A
    Eur J Pharm Biopharm; 2019 Sep; 142():179-194. PubMed ID: 31233861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclodextrins in drug delivery: an updated review.
    Challa R; Ahuja A; Ali J; Khar RK
    AAPS PharmSciTech; 2005 Oct; 6(2):E329-57. PubMed ID: 16353992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions.
    Klang V; Matsko N; Zimmermann AM; Vojnikovic E; Valenta C
    Int J Pharm; 2010 Jun; 393(1-2):152-60. PubMed ID: 20434531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural & synthetically-modified cyclodextrins and polymers in drug delivery systems.
    Otero-Espinar FJ; Blanco-Méndez J
    Curr Top Med Chem; 2014; 14(4):463-4. PubMed ID: 24354673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.